NeuroscienceAnnals of NeurologyPeer-reviewed
GluK2 is a target for gene therapy in drug-resistant Temporal Lobe Epilepsy
Céline Boileau, Séverine Deforges, Angélique Peret…·Valérie Crépel
This study demonstrates that gene therapy targeting GluK2 reduces seizures in TLE models and patient-derived slices.